我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
6
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
4
66.7%
终止
1
16.7%
Unknown
暂无批准数据
- India's fragmented regulatory system, split between Central and State bodies, creates significant challenges for pharmaceutical companies seeking drug approvals and consistent oversight. - Critical shortage of skilled regulatory personnel and trained inspectors hampers effective monitoring and compliance of drug quality standards across the country. - Pharmaceutical companies face multiple regulatory challenges including delayed new drug approvals, inadequate data protection, and slow clinical trial authorization processes.
